PhRMA Backs CREATES, Though It Seeks A Few Changes To The Bill

A top lawyer for the Pharmaceutical Research and Manufacturers of America told senators Tuesday (May 7) that brand drug makers back legislation to ban the industry’s practice of delaying competition by withholding samples needed by generic drug and biosimilars makers to copy brand drugs, though the executive called for changes to the legislation in his written testimony. PhRMA privately backed a watered-down version of the legislation last year, but that was part of a failed bid to gain support for...